Pharmatest Services Ltd invests in latest bone imaging technologies
Pharmatest Services Ltd has purchased two new equipment for bone imaging with most advanced latest technologies, the SkyScan 1276 high resolution desktop in vivo µCT system of Bruker, and the Faxitron UltraFocus DXA digital radiography system of DatecMedico.
Pharmatest Services Ltd (Pharmatest) is a contract research organization that offers preclinical efficacy services for the pharmaceutical industry in the fields of oncology and skeletal diseases. Bone imaging has an important role in the services offered by Pharmatest.
The SkyScan 1276 high resolution desktop in vivo µCT system of Bruker was launched on September 2016. It addresses the latest needs of preclinical imaging in animal studies by reducing the used radiation dose while maintaining highest image quality and spatial resolution.
The Faxitron Ultrafocus DXA digital radiography system of DatecMedico improves the quality and resolution of in vivo X-ray images with an additional option of measuring BMD, BMC, and also lean and fat mass percentages.
Jussi Halleen, CEO of Pharmatest comments: “These new equipment will further improve our strong bone imaging capabilities and provide added value to both our skeletal disease and oncology studies. They allow us to offer our customers high quality follow-up data in rats and mice using latest and most advanced imaging technologies.”